Improvement of visual acuity after photodynamic therapy for choroidal neovascularization in choroidal osteoma [5]

Acta Ophthalmologica Scandinavica

Volumn 83, Issue 4, 2005, Pages 515-516

  Blaise, Pierre ^a   Duchateau, Edouard ^a   Comhaire, Yvette ^a   Rakic, Jean Marie ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN;

ADOLESCENT; CASE REPORT; CHOROID DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DOCTOR PATIENT RELATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LETTER; MEDICAL DECISION MAKING; OPTICAL COHERENCE TOMOGRAPHY; OSTEOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SAFETY; SUBRETINAL NEOVASCULARIZATION; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

EID: 23144464348     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00479.x     Document Type: Letter

References (4)

1. Battaglia Parodi M, Da Pozzo S, Toto L, Saviano S & Ravalico G (2001): Photodynamic therapy for choroidal neovascularization associated with choroidal osteoma. Retina 21: 660-661.
2. Browning DJ (2003): Choroidal osteoma: observations from a community setting. Ophthalmology 110: 1327-1334.
3. Shields CL, Shields JA & Augsburger JJ (1988): Choroidal osteoma. Surv Ophthalmol 33: 17-27.
4. Verteporfin Roundtable 2000 and 2001 Participants, Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Principal Investigators, Verteporfin in Photodynamic Therapy (VIP) Study Group Principal Investigators (2002). Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 22: 6-18.